Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine on PAR-4 levels in resectable solid tumors
NCT02232243Phase 1Completed
- Start
- Jul 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of hydroxychloroquine in solid tumor. Started Jul 2015; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02232243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232243.